NMRD
Nemaura Medical Inc.
Set alert
0.00 USD 0.00 0.00%
0.0002 Day range 0.0002
0.00001 52-week range 0.0005
- YTD
- 0.00%
- 1 year
- -50.00%
- Open
- 0.0002
- Prev close
- 0.0001
- Mkt cap
- 4.04K
- Vol
- 500
- Avg vol
- 429
- EPS
- -0.39
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0002
- High
- 0.0002
- Forward P/E
- -0.08
- Beta
- -0.03
- Short ratio
- 0.30
- Inst. own
- 2.10%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 23, 2024
- 50-d avg
- 0.03986
- 200-d avg
- 0.098785
- 1y target
- 1.50
Key statistics
- Market cap
- 1.41M
- Enterprise value
- 20.40M
- Trailing P/E
- 0.00
- Forward P/E
- -0.08
- PEG ratio
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- -0.39
- Beta
- -0.03
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -10.07M
- Total cash
- 137.42K
- Total debt
- 19.64M
- Return on equity
- 0.00%
- Shares outstanding
- 40.35M
- Short % of float
- 0.31%
- 50-day average
- 0.03986
- 200-day average
- 0.098785
Analyst view
Consensus: buy
Buy
Price target (mean) 1.50
Next earnings
Dec 23, 2024
Expected Dec 23, 2024. Consensus EPS estimate 0.00.
Financials — quick view
NMRD Revenue — quarterly 0
NMRD Net income — quarterly -1.20M
NMRD EPS — quarterly -0.05
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 23, 2024 | Sep 1, 2024 | 0.00 | — | — | — |
| Sep 30, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jul 11, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Feb 12, 2024 | Dec 1, 2023 | 0.00 | -0.12 | — | — |
| Nov 13, 2023 | Sep 1, 2023 | -0.10 | -0.11 | -0.01 | -10.00% |
| Aug 14, 2023 | Jun 1, 2023 | -0.14 | -0.09 | +0.05 | +35.71% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 20, 2023 | HC Wainwright & Co. | main | Buy | Buy |
| Jul 16, 2023 | EF Hutton | main | Buy | Buy |
| Mar 29, 2023 | EF Hutton | reit | — | Buy |
| Feb 27, 2023 | EF Hutton | main | — | Buy |
| Feb 26, 2023 | HC Wainwright & Co. | main | — | Buy |
| Aug 18, 2022 | HC Wainwright & Co. | main | — | Buy |
About Nemaura Medical Inc.
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- nemauramedical.com
News
- Reviewing InfuSystem (NYSE:INFU) and Nemaura Medical (OTCMKTS:NMRD)
- Important Update on Listing Status and Strategic Direction
- Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
- Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
- Nemaura (NMRD) to Expand in UK With Metabolic Health Program
- Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs
- Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- Stocks That Hit 52-Week Lows On Friday
- Stocks That Hit 52-Week Lows On Thursday
Your note
Sign in to keep a note on NMRD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GHADAR-GHADR ARASH | Chief Operating Officer | Purchase | Jan 4, 2024 | 100,000 |
| MCLARNEY JUSTIN JAMES | Chief Financial Officer | Stock Award(Grant) | Jan 30, 2022 | 22,293 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Alyeska Investment Group, L.p. | 8.59% | 2,483,271 | 2.30M | Jun 29, 2023 |
| Vanguard Group Inc | 0.45% | 130,861 | 121.06K | Jun 29, 2023 |
| Geode Capital Management, LLC | 0.37% | 107,897 | 99.81K | Jun 29, 2023 |
| State Street Corporation | 0.19% | 53,666 | 49.65K | Jun 29, 2023 |
| Northern Trust Corporation | 0.09% | 26,737 | 24.73K | Jun 29, 2023 |
| Tower Research Capital LLC (TRC) | 0.03% | 7,328 | 6.78K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.44% | 126,682 | 117.19K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.23% | 67,468 | 33.66K | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.05% | 15,517 | 7.74K | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.04% | 11,700 | 5.84K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.02% | 7,006 | 3.50K | May 30, 2023 |
| Master Investment Portfolio-Diversified Equity Master Portfolio | 0.01% | 2,006 | 1.85K | Jun 29, 2023 |